Selvita is a preclinical CRO providing multidisciplinary support in resolving challenges of research within the area of drug discovery and drug development. Selvita was established in 2007 and currently employs over 1000 professionals, of which over 40% hold a PhD degree. The Company research sites are located in Krakow (HQ) and Poznan, Poland, as well as Zagreb, Croatia. The company offers drug discovery support at every stage of the early discovery phase up to the preclinical development.